A detailed history of Sonic Gp LLC transactions in Uni Qure N.V. stock. As of the latest transaction made, Sonic Gp LLC holds 50,000 shares of QURE stock, worth $282,500. This represents 0.46% of its overall portfolio holdings.

Number of Shares
50,000
Previous 50,000 -0.0%
Holding current value
$282,500
Previous $260 Million 13.85%
% of portfolio
0.46%
Previous 0.34%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$18.12 - $27.32 $906,000 - $1.37 Million
50,000 New
50,000 $1.13 Billion

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $264M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Sonic Gp LLC Portfolio

Follow Sonic Gp LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sonic Gp LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sonic Gp LLC with notifications on news.